The Winners Circle Introduces Skill2Earn to Horse Racing
HONG KONG–(BUSINESS WIRE)–#Skill2Earn—The Winners Circle is a fan loyalty platform launched by esteemed horse racing competition Racing League... Read more.
Press Ganey Announces Strategic Investment in Charge Health, a New Mobile App for Caregivers
Charge Health is a mobile social game that builds workplace cultures of belonging by connecting caregivers to the “why” behind their work for improved retention... Read more.
B Capital Builds a World-Class Climate Investment Platform
Rich Lesser Joins as Vice Chair, Climate & Sustainability and Senior Advisor Jeff Johnson Joins as General Partner Leading Climate NEW YORK–(BUSINESS WIRE)–B... Read more.
Gennao Bio Announces Upcoming Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024
– Poster presentation to highlight the application of Gennao’s gene monoclonal antibody (GMAB) platform as an antibody-drug conjugate (ADC) for solid tumors... Read more.
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
Total Net Sales in Excess of $77 Million Including Record Quarterly U.S. ICL Sales of $5 Million LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company... Read more.
SolarEdge Acquires Wevo Energy, EV Charging Optimization and Management Software Startup
MILPITAS, Calif.–(BUSINESS WIRE)–SolarEdge Technologies, Inc. (“SolarEdge”) (NASDAQ: SEDG), a global leader in smart energy technology, today announced... Read more.
AECOM consortium selected to deliver Australia’s M80 Ring Road Completion
DALLAS–(BUSINESS WIRE)–AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced that the Victoria State Government has... Read more.
LTIMindtree Partners with Aforza to Setup Training Academy
To deliver Digital Transformation in CRM & TPM across consumer products industry, globally LONDON & MUMBAI, India–(BUSINESS WIRE)–$LTIM #AI—Aforza,... Read more.
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced it has initiated a Phase 3 clinical... Read more.
RPM Reports Record Fiscal 2024 Third-Quarter Results
Record third-quarter net sales of $1.52 billion, up 0.4% from the prior year Record third-quarter net income of $61.2 million, record diluted EPS of $0.47, and record... Read more.